HIV-1 long terminal repeat-dependent transcription machinery (HIV-1 LTR transcription machinery)

The HIV-1 long terminal repeat-dependent transcription machinery is a complex functional unit responsible for the expression of the integrated HIV-1 provirus. The process is governed by the 5' Long Terminal Repeat (LTR), which acts as a promoter containing binding sites for host transcription factors such as NF-κB, SP1, and AP-1 (Cullen, 1991, J. Virol.). A pivotal component of this machinery is the viral Trans-activator of transcription (Tat) protein, which binds to the Trans-activation Response (TAR) RNA element. This interaction recruits the host Positive Transcription Elongation Factor b (P-TEFb) complex, consisting of CDK9 and Cyclin T1, which phosphorylates the C-terminal domain of RNA polymerase II to drive efficient transcriptional elongation (Wei et al., 1998, Cell). In the context of disease, this machinery is the primary driver of viral replication and the maintenance of the latent HIV reservoir, which remains the chief obstacle to a cure. Therapeutic strategies targeting this machinery include 'Shock and Kill' approaches, which use latency-reversing agents (LRAs) like HDAC inhibitors to activate the LTR and expose infected cells to immune clearance (Deeks, 2012, Nature). Conversely, 'Block and Lock' strategies utilize Tat inhibitors like didehydro-cortistatin A (dCA) to epigenetically silence the LTR and prevent viral reactivation (Mousseau et al., 2015, mBio). Because the machinery relies heavily on host factors like CDK9, drug development must balance potent viral inhibition with the risk of host cell toxicity.

Other names

HIV-1 LTR promoter complexTat-TAR-P-TEFb complexHIV-1 transcriptional elongation machineryHIV-1 proviral transcription complex

Inhibition of Tat-mediated recruitment of P-TEFb to the TAR RNA element, inhibition of CDK9-mediated phosphorylation of RNA polymerase II, or epigenetic modulation of the LTR promoter to either induce or suppress viral transcription.